U.S. Other Utilities Stock News

Cadence Design Systems stock barely flinched after earnings. Shares were up about 1.8% to US$344.72 by the close, even as the company posted what looks like one of its cleanest quarters in years. Revenue landed at US$1.584b with non GAAP operating margin at 45.5%, powered by heavy demand for chip design and verification tools tied to artificial intelligence. The real story for long term investors is not today’s modest price move. It is the raised full year outlook and an US$8.1b backlog that...

In recent weeks, multiple law firms filed securities class action lawsuits against Wix.com Ltd., accusing the company of misleading investors about the competitiveness, performance, and costs of its AI initiatives and related platforms such as Base44 and Harmony, following disappointing Q1 2026 results and sharply higher operating expenses. This wave of litigation highlights how aggressively front-loaded AI compute spending and a reshaped cost structure have become central issues for...

Western Midstream Partners has delivered very strong returns over the past few years, and the stock now trades with an undervalued signal on market multiples while the broader valuation checks point to a more mixed picture. For investors, the question is whether the recent share price strength still leaves enough valuation support. Western Midstream Partners has returned about 267.2% over the past 5 years, which puts long term holders in a strong position and raises the bar for any new...

India’s sports scene is shifting fast as Wimbledon’s India focused push, rising tennis viewership and growing sponsorship interest draw more attention to how streaming platforms and advertisers reach premium urban audiences. That kind of change can help some stocks and squeeze others, depending on how exposed they are to this news and how they earn their revenue. This article breaks down three India Sports Engagement Stocks Linked to Streaming and Sponsorship Shifts, with one that appears...

The latest move from Audi to push deeper into the U.S. luxury SUV market with its new Q9, SQ9 and refreshed Q3 and Q7 ranges is a reminder that tariffs, incentives and product mix can matter as much as brand strength. Audi’s lack of U.S. manufacturing and the recent 17% sales decline in the first half of 2026 underline how quickly conditions can shift. For investors looking at luxury automobile manufacturers exposed to this news, the goal is to separate potential beneficiaries from those...

Arlo Technologies has delivered a 129.9% share price gain over the past 5 years, yet its current valuation picture is mixed, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while earnings based multiples look less generous. At the same time, the stock trades at US$14.23 with a value score that does not clearly place it in either the bargain or expensive camp. Over 5 years, Arlo Technologies has returned 129.9%, which puts the recent share price in...

Dover (DOV) is back in focus after its latest quarterly results, with second quarter sales reaching US$2,190.02 million and net income of US$312.25 million, supported by stronger performance in Asia than in Europe. See our latest analysis for Dover. The latest earnings release came as the share price eased, with Dover’s stock falling around 10% over the past month and drifting lower over the past quarter, even though the 1 year total shareholder return of 11.49% and 3 year total shareholder...

Kilroy Realty stock slipped about 1.9% to US$38.66 after its Q2 report, which keeps the 7 day move slightly in the red but leaves the 90 day run still firmly positive. The headline from this quarter is a profit squeeze. Funds From Operations per share, the core yardstick for office real estate investment trusts, printed at US$0.93, well below where it sat in mid 2025. Net income for the quarter came in at US$19.9m, a sharp step down from last year’s peaks. Short term traders are reacting to...

Traders just marked Axalta Coating Systems up roughly 5% in a single session, yet the real story sits inside the margin sheet. Q2 brought record adjusted earnings before interest, taxes, depreciation and amortization of US$305 million and a Q2 high adjusted EBITDA margin of 22.7%. The question is whether this jump in the stock is simply momentum or a rational reprice of a coatings business that is squeezing more profit out of each dollar of sales. Is Axalta Coating Systems trading at a...

MakeMyTrip stock edged up 2.6% to US$53.72 after earnings, a modest move for a company priced on big growth expectations and a trailing P/E near 97x. The headline this quarter is not the share price pop. It is the strain between rich valuation, a thinner net profit margin of 5% over the last year and weak interest coverage. Investors are being asked to pay well above an estimated cash flow value for MakeMyTrip while accepting a business that currently converts far less of its large booking...

Incyte stock just jumped 9.3% in a single session, yet the real story is not the share price spike. The company delivered what the market has been waiting for in biotech, with revenue for Q2 2026 reaching US$1.67b and basic earnings per share at US$2.92. The one day move reflects investors suddenly pricing in a business that now appears more profitable and more diversified than it did even a few quarters ago. Impressed by Incyte’s Q2 2026 earnings strength but want more stocks that pair solid...

In July 2026, First Interstate BancSystem reported second-quarter 2026 net income of US$83.9 million and diluted earnings per share of US$0.87, while also disclosing higher net loan charge-offs of US$9.7 million and announcing a US$0.47 quarterly dividend. Over the same period, the board completed a share repurchase of approximately 7.98 million shares and expanded its buyback authorization to US$450 million, signalling continued use of capital returns alongside board refreshment with two...

Recent coverage in July 2026 highlighted that Macy’s is now rated a Zacks Rank #1 (Strong Buy), with earnings estimates revised higher and valuation metrics such as P/E, P/B and P/CF suggesting the stock is trading at an attractive discount to industry peers. At the same time, Macy’s appointment of Alexandre Choueiri to lead Bluemercury is reshaping how investors view its presence in prestige beauty and the company’s overall business mix. We’ll now examine how Macy’s perceived...

iRhythm Holdings (IRTC) is back on investor radars after recent trading, with the stock closing at US$117.37. The move comes against a backdrop of mixed short and longer term share price performance. See our latest analysis for iRhythm Holdings. The strong 1 day share price return of 4.65% and 7 day share price return of 7.68% come after a weaker run, with the year to date share price return down 33.02% and the 1 year total shareholder return down 14.18%. However, the 5 year total shareholder...

Metropolitan Bank Holding Corp. recently reported its second-quarter 2026 results, with net interest income rising to US$90.45 million and net income edging up to US$19.22 million, while basic earnings per share from continuing operations eased to US$1.55 from US$1.78 a year earlier. Across the first half of 2026, the bank’s net income increased to US$50.65 million and diluted earnings per share from continuing operations reached US$4.40, alongside a board-approved quarterly dividend...

Tech stocks are under pressure after a sharp global semiconductor sell off, yet many investors are looking at the other side of their portfolios. Large consumer staples stocks can sometimes offer a steadier ride when chip stocks swing sharply. This article focuses on three companies from a Defensive Consumer Staples Stocks screener that appear closely exposed to the current news backdrop, whether through their role in everyday spending or their perceived lower risk profile. You will see how...

Outlook Therapeutics recently received U.S. FDA approval for LYTENAVA (bevacizumab‑vikg) to treat neovascular (wet) age-related macular degeneration, making it the first and only FDA‑approved ophthalmic bevacizumab in the U.S. retina market. This approval, which the company believes qualifies LYTENAVA for 12 years of Reference Product Exclusivity under the Biologics Price Competition and Innovation Act, positions Outlook Therapeutics in an approximately US$8.50 billion annual U.S. anti‑VEGF...

Evercore Inc. reported its Q2 2026 results on July 29, 2026, holding its earnings call the same day after releasing numbers before the US market opened. The market’s focus is on Evercore’s upcoming revenue growth expectations and its history of outperforming analyst estimates, which together are shaping sentiment ahead of this earnings season. We’ll now explore how Evercore’s upcoming Q2 earnings report and history of beating expectations could influence its broader investment...

Affiliated Managers Group recently issued guidance for its second-quarter 2026 results, indicating an adjusted EBITDA range of US$290 million to US$305 million and highlighting continued strength in its earnings surprise track record. The company’s current Zacks Rank #2 (Buy) and positive Earnings ESP of 1.86% have reinforced investor focus on how its diversified affiliates may sustain performance. We’ll now examine how AMG’s guided adjusted EBITDA range for the quarter may influence its...

Synaptics stock has delivered a strong 70.9% return over the past year, yet its valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while traditional market multiples suggest the shares may still be priced attractively. Over the past 12 months Synaptics has returned 70.9%, which places recent share price momentum firmly on the positive side for existing holders. Future growth in cash flows from Synaptics' semiconductor solutions can...

Astronics Corporation recently received a favorable ruling from a UK appellate court in its patent dispute with Lufthansa Technik AG, which dismissed Lufthansa Technik’s appeal and ordered a partial refund to Astronics. This court outcome not only returns cash to Astronics but also strengthens the company’s legal position around its intellectual property protection efforts. We’ll now examine how this favorable patent ruling, including the ordered partial refund, reshapes Astronics’ existing...

Zions Bancorporation, National Association recently completed a US$500,000,000 fixed-to-floating rate senior note offering due October 1, 2029, while also reporting second-quarter 2026 results that showed higher net interest income and net income versus the prior year. Alongside this earnings strength, Zions finished a US$75,000,000 share repurchase program in the quarter, signaling active balance sheet and capital management. With these stronger quarterly earnings and completed buybacks,...

First Guaranty Bancshares stock inched up about 3% to US$9.64 after its second quarter report, a modest move for a bank that has put investors through sharp swings over the past year. The market reaction looks calm on the surface, yet the headline is more dramatic. Earnings per share landed at roughly US$0.17 and net income reached about US$2.8 million, while non performing loans continued to weigh on the story. The key issue is how long this repair job on credit quality and profitability can...

InterDigital stock has delivered a very large 5 year return, yet the latest valuation checks paint a more mixed picture, which raises questions about how much of that progress is already reflected in the current price. Over the past 5 years, InterDigital shares have gained about 308%, which puts long term holders in a strong position but makes the current entry point more sensitive to valuation assumptions. Recent moves to extend its patent licensing into connected EV chargers and highlight...